Greeley-based University of Northern Colorado was granted $1 million from HHS to collaborate with Denver-based digital health company Cliexa to study technology used to identify high-risk adolescents.
With the funding, the university will support a 700-person clinical trial. Patients will leverage Cliexa's risk screening tool, which is a digital platform and mobile health follow-up program.
During the two-year study, researchers at UNC will assess the effectiveness of deploying the digital health technology in clinical workflows. Additionally, the university will evaluate the benefits of earlier identification of adolescents who have higher risks of adverse health outcomes.
"We will assess the quad aims of patient/provider satisfaction, reduced costs and improved outcomes with this study," said Cliexa Options Senior Advisory Lisa Rue, PhD. "We want to empower clinicians and providers to do what they do best — counsel patients and encourage optimal wellness."